Achieve Life Sciences, Inc.
ACHV · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $112,890 | $81,689 | $25,953 | $63,172 |
| - Cash | $12,753 | $15,546 | $24,771 | $43,022 |
| + Debt | $9,958 | $16,731 | $16,198 | $73 |
| Enterprise Value | $110,095 | $82,874 | $17,380 | $20,223 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$229 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$37,418 | -$26,734 | -$40,325 | -$32,902 |
| % Margin | – | – | – | – |
| Net Income | -$39,827 | -$29,815 | -$42,350 | -$33,152 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.24 | -1.5 | -3.95 | -4.05 |
| % Growth | 17.3% | 62% | 2.5% | – |
| Operating Cash Flow | -$29,770 | -$24,479 | -$37,569 | -$29,440 |
| Capital Expenditures | $0 | -$21 | $0 | $0 |
| Free Cash Flow | -$29,770 | -$24,500 | -$37,569 | -$29,440 |